Compare PBF & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBF | LGND |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.9B |
| IPO Year | 2012 | 1992 |
| Metric | PBF | LGND |
|---|---|---|
| Price | $26.10 | $189.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $30.64 | ★ $239.33 |
| AVG Volume (30 Days) | ★ 2.6M | 212.6K |
| Earning Date | 02-12-2026 | 11-06-2025 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | N/A | ★ 0.76 |
| EPS | N/A | ★ 2.49 |
| Revenue | ★ $29,544,100,000.00 | $251,233,000.00 |
| Revenue This Year | N/A | $52.87 |
| Revenue Next Year | $3.13 | $6.07 |
| P/E Ratio | ★ N/A | $78.37 |
| Revenue Growth | N/A | ★ 64.83 |
| 52 Week Low | $13.62 | $93.58 |
| 52 Week High | $41.48 | $212.49 |
| Indicator | PBF | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 28.55 | 42.70 |
| Support Level | $25.90 | $194.44 |
| Resistance Level | $26.95 | $198.80 |
| Average True Range (ATR) | 1.17 | 5.59 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 9.10 | 42.58 |
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.